Description

AOD 9604 Research Grade Compound Handbook Product Overview

AOD9604 is a modified hGH fragment (176-191) with a di-sulfide bridge, derived from human growth hormone. Initially designed for fat burning, it promotes lipolysis and blocks lipogenesis. Studies suggest potential benefits for heart health, osteoarthritis, cartilage repair, and metabolic syndrome.This product is for scientific research purposes only and is not intended for human or veterinary clinical use.This product is for scientific research purposes only and is not intended for human or veterinary clinical use.

main features
·   High purity: HPLC verification purity ≥ 99%
·   Research focus: AOD9604 was initially developed as a weight loss drug due to its lipolytic (fat burning) properties. The value of this peptide is that it has almost no other function besides burning fat. It does not seem to affect IGF-1 levels or insulin levels, so it is not a risk factor for glucose intolerance or diabetes . In addition, due to the similarity in structure between AOD9604 and HGH, which does not stimulate immune system responses, there is no evidence to suggest that the human body will form antibodies against AOD9604
·   Appearance: Peptide in freeze-dried (powder) form
·   Packaging specification: 10mg standard packaging (can be customized according to requirements)
·   Cold chain transportation: Ensure temperature throughout the entire process (-20 ℃)

Disclaimer ExemptionIt should be ensured that:
Comply with the laboratory’s “Regulations on the Management of Hazardous Chemicals” and local regulations
Established compound lifecycle tracking system
Any consequences resulting from authorized resale or non scientific use shall be borne by the user themselves